Lv4
590 积分 2021-04-30 加入
Brief report: Ivonescimab combined with etoposide plus carboplatin as first-line treatment for extensive-stage small-cell lung cancer: results of a phase Ib clinical trial
24天前
已关闭
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
24天前
已完结
Mechanisms of Resistance to Tyrosine Kinase Inhibitors in ROS1 Fusion-Positive Nonsmall Cell Lung Cancer
1个月前
已完结
Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development
1个月前
已关闭
New promises and challenges in the treatment of advanced non-small-cell lung cancer
1个月前
已完结
Understanding and targeting resistance mechanisms in NSCLC
1个月前
已完结
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
1个月前
已完结
Anti-Vascular Endothelial Growth Factor/Programmed Cell Death Protein 1 Bispecific Antibodies: Using Nunchucks to Fight an Old Adversary
1个月前
已完结
Cisplatin-loaded nanoformulations for cancer therapy: A comprehensive review
2个月前
已完结
Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World)
3个月前
已完结
皖公网安备34019202002308
